NCT01549769View on ClinicalTrials.gov

Pharmacokinetic and Pharmacodynamic Study of Bardoxolone Methyl in Patients With Chronic Kidney Disease and Type 2 Diabetes

PHASE1TerminatedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

November 30, 2012

Study Completion Date

October 31, 2013

Conditions
Renal Insufficiency, ChronicDiabetes Mellitus, Type 2
Interventions
DRUG

Bardoxolone Methyl

Oral, once daily

Sponsors

Lead Sponsor

Biogen
All Listed Sponsors
lead

Biogen

INDUSTRY